Sam L. Barker, Director at CADENCE PHARMACEUTICALS INC (CADX), bought 11,000 shares at $5.19 ($58K) on 2008-03-17, disclosed to the SEC on 2008-03-19.
Open-market purchase of $58k CADX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.16 | 1,828 | $9K | 16.3% |
| 2 | $5.17 | 432 | $2K | 3.9% |
| 3 | $5.19 | 56 | $291 | 0.5% |
| 4 | $5.20 | 3,000 | $16K | 27.0% |
| 5 | $5.20 | 684 | $4K | 6.2% |
| 6 | $5.23 | 445 |
| $2K |
| 4.0% |
| 7 | $5.25 | 806 | $4K | 7.3% |
| 8 | $5.32 | 599 | $3K | 5.5% |
| 9 | $5.34 | 100 | $534 | 0.9% |
| 10 | $5.35 | 749 | $4K | 6.9% |
| 11 | $5.35 | 1,301 | $7K | 12.1% |
| 12 | $5.37 | 1,000 | $5K | 9.3% |
| Total | $5.25 avg | 11,000 | $58K | 100% |
| Filing → |
| LXRX | BUY | 2019-08-02 | $28K | — | Filing → |
| LXRX | BUY | 2017-09-18 | $13K | — | Filing → |
| CYCC | BUY | 2014-11-20 | $9K | — | Filing → |